Clinical Trials Directory

Trials / Completed

CompletedNCT00213525

Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls

Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Healthy Controls

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years – 76 Years
Healthy volunteers
Accepted

Summary

Scleroderma is an autoimmune disease of unknown origin. Recently, the role of environmental factors, and particularly toxic drug exposure, in the genesis of scleroderma has been suggested. This prompted us to conduct this prospective, case-control, multicentric study, including 2 groups of subjects: * 100 patients with scleroderma * 300 sex- and age-matched healthy controls. The aim of our study is to determine whether exposure to toxics is higher in patients with scleroderma compared with healthy controls.

Detailed description

The data of patients with scleroderma and healthy controls will be compared regarding: * a standardized questionnaire about "cursus laboris" at initial inclusion * a search for toxics in blood, urine and hair: at initial exvaluation, 6 month and 2 year-follow-up

Conditions

Interventions

TypeNameDescription
OTHERQuestionnary for environmental factors researchQuestionnary for environmental factors research

Timeline

Start date
2004-10-01
Primary completion
2008-10-01
Completion
2008-10-01
First posted
2005-09-21
Last updated
2015-02-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00213525. Inclusion in this directory is not an endorsement.